Target intelligence / Profile preview

Lipid bilayer of cell membrane or viral envelope

Molecular classification
Other (structural biological membrane, not a traditional molecular drug target), Biological membrane
01

Overview

The **lipid bilayer** (also referred to as the **phospholipid bilayer**) is the fundamental structural component of the membranes surrounding all cells and many viruses[5][1][3][7]. In cells, it forms the plasma membrane, providing a selectively permeable barrier that separates the interior of the cell from the external environment, controls the movement of substances, and supports a variety of embedded proteins for transport, signaling, and cell-to-cell communication[1][5][3][7]. The lipid bilayer consists of two opposing layers of amphiphilic lipid molecules (primarily phospholipids), with hydrophilic head groups facing the aqueous environment and hydrophobic tails facing each other, forming the membrane's core[1][5]. Membrane fluidity and properties are modulated by components such as cholesterol and, in specialized cases, glycolipids[3][7]. For **viruses** with envelopes (e.g., influenza, HIV, coronaviruses), the viral envelope is also made of a lipid bilayer, derived from the host cell membrane as the virus buds off from the host[2][6][8]. Viral envelopes contain viral glycoproteins necessary for host cell attachment and entry, mediating fusion between the viral and host membranes[2][6][8]. The lipid bilayer itself is not a direct drug target. Therapeutic interventions typically focus on proteins or glycoproteins embedded within or associated with the bilayer, such as viral fusion proteins or cellular receptors[2][6][8]. Experimental agents or detergents can disrupt bilayer structure, but this is generally cytotoxic and not a viable therapeutic strategy[5][6]. Due to its ubiquitous structural role and lack of unique molecular features, the lipid bilayer is not classified as a canonical "drug target" such as a receptor, enzyme, or ion channel, but as a **biological membrane** and permeability barrier[5][7]. Drugs interact with or disrupt the bilayer indirectly, primarily as a side effect or in experimental contexts rather than as a focused therapeutic mechanism.

Other names
Phospholipid bilayerCell membrane lipid bilayerViral envelope lipid bilayerPlasma membrane lipid bilayer
02

Mechanism of action

Disruption of membrane integrity (cell lysis or viral inactivation, e.g., detergents) Inhibition of membrane fusion (blocking viral entry) Modification of membrane fluidity or lipid composition (affects embedded protein function) None specific for drugs, as lipid bilayer is rarely the primary therapeutic target

03

Biological functions

Permeability barrier for cells and virusesMediation of fusion and entry (for viral envelopes)Maintenance of cellular compartmentalizationAnchoring site for membrane proteins (including receptors, enzymes, transporters)Signal transduction support (via embedded proteins and lipid signaling molecules)Regulation of cell volume and osmotic balance
04

Disease associations

Infection (role as the entry site for many enveloped viruses)Other (loss of membrane integrity contributes to cell injury and death)Cancer (changes in membrane composition and signaling)Cardiovascular disease (membrane cholesterol effects on signaling and homeostasis)
05

Safety considerations

Disrupting lipid bilayers is toxic to normal cells (loss of barrier function)Nonspecific membrane disruption can lead to cell lysis, cytotoxicity, or hemolysisViral membrane targeting may affect host membranesDifficulty in achieving selectivity, as all living cells and many organelles have lipid bilayers
06

Interacting drugs

Detergents (disrupt the bilayer, used experimentally)

4 more in the full profile.

07

Biomarkers

Membrane composition markers (e.g., lipidomics for diagnostic purposes)Cholesterol/phospholipid ratios (sometimes used for research or cardiovascular risk)Presence of viral envelope proteins (like HIV gp120) used as indirect biomarkers; not the bilayer itself

Beyond the preview

Go deeper on Lipid bilayer of cell membrane or viral envelope.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid bilayer of cell membrane or viral envelope.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call